{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:22:31Z","timestamp":1781976151280,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26293029"],"award-info":[{"award-number":["26293029"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kuraray Co., Ltd., Japan"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbrc.2018.12.124","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T07:41:22Z","timestamp":1545550882000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives"],"prefix":"10.1016","volume":"509","author":[{"given":"Yuya","family":"Ohtsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-0951","authenticated-orcid":false,"given":"Seigo","family":"Sanoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Santoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ejiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaichiro","family":"Kotake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.12.124_bib1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/dmd.116.070763","article-title":"Prevalence of non-cytochrome P450-mediated metabolism in food and drug administration-approved oral and intravenous drugs: 2006-2015","volume":"44","author":"Cerny","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2018.12.124_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucoronosyl transferase substates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2018.12.124_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2018.12.124_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/03602532.2016.1195403","article-title":"Hepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame","volume":"48","author":"Kim","year":"2016","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbrc.2018.12.124_bib5","doi-asserted-by":"crossref","first-page":"21373","DOI":"10.1038\/srep21373","article-title":"Acetaminophen induces accumulation of functional rat CYP3A via polyubiquitination dysfunction","volume":"6","author":"Santoh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2018.12.124_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/tx00034a019","article-title":"Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics","volume":"6","author":"Patten","year":"1993","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/tx9701687","article-title":"Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6","volume":"11","author":"Chen","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/0006-2952(93)90295-8","article-title":"Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by Human CYP3A4","volume":"45","author":"Thummel","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","article-title":"Acetaminophen-induced hepatotoxicity","volume":"31","author":"James","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2018.12.124_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2017.03.073","article-title":"Acetaminophen analog N-acetyl-m-aminophenol, but not its reactive metabolite, N-acetyl-p-benzoquinone imine induces CYP3A activity via inhibition of protein degradation","volume":"486","author":"Santoh","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.12.124_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.tiv.2014.05.007","article-title":"Fluorometric assessment of acetaminophen-induced toxicity in rat hepatocyte spheroids seeded on micro-space cell culture plates","volume":"28","author":"Sanoh","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.bbrc.2018.12.124_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1083\/jcb.43.3.506","article-title":"High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study","volume":"43","author":"Berry","year":"1969","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib13","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1038\/cddis.2013.150","article-title":"Protein tyrosine phosphatase 1B modulates GSK3b\/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity","volume":"4","author":"Mobasher","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2018.12.124_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/MCB.18.1.78","article-title":"Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation","volume":"18","author":"Schwenger","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib15","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1091\/mbc.E15-02-0120","article-title":"p38 MAP kinase-dependent phosphorylation of the Gp78 E3 ubiquitin ligase controls ER-mitochondria association and mitochondria motility","volume":"26","author":"Li","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2018.12.124_bib16","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.18632\/oncotarget.1478","article-title":"Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2018.12.124_bib17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1242\/jcs.176537","article-title":"Ubiquitin-mediated regulation of the E3 ligase GP78 by MGRN1 in trans affects mitochondrial homeostasis","volume":"129","author":"Mukherjee","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.bbrc.2018.12.124_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.115.066720","article-title":"Key findings from preclinical and clinical drug interaction studies presented in new drug and biological license applications approved by the FDA in 2014","volume":"44","author":"Yu","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbrc.2018.12.124_bib19","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/mol.65.2.470","article-title":"Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts","volume":"65","author":"Mifflin","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.12.124_bib20","first-page":"1827","article-title":"Role of the nuclear receptor pregnane X receptor in acetaminophen hepatotoxicity","volume":"33","author":"Wolf","year":"2005","journal-title":"Drug Metab. Dispos."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18327773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18327773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T04:22:22Z","timestamp":1546230142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18327773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0006291X18327773"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.124","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}